Nerve Stimulation for the Treatment of Obstructive Sleep Apnea.

ABSTRACT:

Purpose

This review will trace the elements of neurostimulation for obstructive sleep apnea and details on its implementation, efficacy and safety, immediate clinical outcomes, and future prospects.

Methods

The literature on upper airway neurostimulation was surveyed from July, 2013, to July 2019, with a focus on the components of devices, evidence for clinical utility, and adverse events.

Results

Current technology is focused on the hypoglossal nerve stimulation (HNS). The most long-term experience is with the Inspire Medical System (Maple Grove, MN USA) which has both FDA and European regulatory approval. Given the inclusion criteria (BMI <35, ideally <32), AHI 15-65/h, and a favorable anterior-posterior velopharyngeal collapse pattern on DISE), across many centers

SUBMITTER: Yamauchi M 

PROVIDER: S-EPMC10686243 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature